FRACTYL HEALTH, INC.(GUTS)Stock Analysis
AI analysis on 2,800+ stocks →Deep AI analysis on 2,800+ stocks →13F Pro Quality Score
Not in ranked universe
Below size threshold
Quality rankings require at least $50M annual revenue or $250M total assets to filter out micro-caps and shell companies. This company reported $0.1M in revenue.
Financial data, filings, and institutional holdings below are still tracked in full — only the proprietary quality composite is unavailable for this name.
GUTS Stock Analysis & AI Quality Score
AI stock analysis and institutional research for FRACTYL HEALTH, INC. (GUTS), a Healthcare sector company. GUTS is not currently included in 13F Pro's AI-ranked quality universe — quality rankings require at least $50m annual revenue or $250m total assets to filter out micro-caps and shell companies. this company reported $0.1m in revenue. Based on the latest XBRL financial filings (Q1 2026), FRACTYL HEALTH, INC. reports net income of $9.2M, free cash flow of $-22.5M. Top institutional holders of GUTS by reported 13-F value include Nantahala Capital Management,, 683 Capital Management,, Pale Fire Capital SE, based on the most recent SEC filings. GUTS trades on the Nasdaq exchange and files with the SEC under CIK 1572616. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate GUTS daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for FRACTYL HEALTH, INC. directly from SEC EDGAR.
Net Income
Q1 2026
$9.2M
Free Cash Flow
Q1 2026
$-22.5M
Revenue & Net Income
Earnings Per Share
Key Financials Over Time
Export Financial Table · Pro+Revenue
-100.0% YoYNet Income
-105.2% YoYOperating Income
-3.5% YoYEPS (Diluted)
-14.8% YoYTotal Assets
+12.3% YoYOp. Cash Flow
-37.9% YoY| Metric | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|
| Revenue | $0.00 -100.0% | $93.0K -22.5% | $120.0K |
| Net Income | $-141.0M -105.2% | $-68.7M +10.9% | $-77.1M |
| Operating Income | $-96.8M -3.5% | $-93.5M -84.0% | $-50.8M |
| EPS (Diluted) | $-1.86 -14.8% | $-1.62 +96.4% | $-45.29 |
| Total Assets | $121.4M +12.3% | $108.1M +41.8% | $76.2M |
| Operating Cash Flow | $-90.3M -37.9% | $-65.5M -53.0% | $-42.8M |
Get alerted when GUTS's score changes
Free account: watchlist tracking, the daily AI brief, and the AI screener.
Available Research
13F Pro tracks comprehensive data for FRACTYL HEALTH, INC. including:
Top Institutional Holders of GUTS
Nantahala Capital Management, LLC
$6.1M13,364,519 sh683 Capital Management, LLC
$3.1M6,727,235 shPale Fire Capital SE
$2.7M5,921,045 shVANGUARD CAPITAL MANAGEMENT LLC
$2.5M5,533,006 shCatalio Capital Management, LP
$2.5M5,491,866 shGeneral Catalyst Group Management, LLC
$2.2M4,884,193 shDeer Management Co. LLC
$2.2M4,770,901 shMAVERICK CAPITAL LTD
$1.8M3,974,806 shWoodline Partners LP
$1.0M2,241,679 shBlackRock, Inc.
$979.6K2,139,837 sh
| Fund | Value | Shares |
|---|---|---|
| Nantahala Capital Management, LLC | $6.1M | 13,364,519 |
| 683 Capital Management, LLC | $3.1M | 6,727,235 |
| Pale Fire Capital SE | $2.7M | 5,921,045 |
| VANGUARD CAPITAL MANAGEMENT LLC | $2.5M | 5,533,006 |
| Catalio Capital Management, LP | $2.5M | 5,491,866 |
| General Catalyst Group Management, LLC | $2.2M | 4,884,193 |
| Deer Management Co. LLC | $2.2M | 4,770,901 |
| MAVERICK CAPITAL LTD | $1.8M | 3,974,806 |
| Woodline Partners LP | $1.0M | 2,241,679 |
| BlackRock, Inc. | $979.6K | 2,139,837 |
More Healthcare Companies
View all Healthcare →Put GUTS on your watchlist
Track score changes the day FRACTYL HEALTH, INC. files with the SEC, follow the hedge funds that own it, screen 2,800+ AI-scored stocks, and get the daily brief — free.
Free tier includes 13F data, economic indicators, and market overview. Pro starts at $6.67/mo (billed annually).
Popular Research
Is GUTS a good stock to buy?
13F Pro's AI-powered analysis of FRACTYL HEALTH, INC. (GUTS) draws on SEC EDGAR-sourced fundamentals, institutional 13F holdings, and insider Form 4 transactions in the Healthcare sector (listed on Nasdaq). The 32-signal AI Quality Score, current rank, and full bull/bear verdict for GUTS are available on the GUTS stock profile dashboard — with the same data, AI insights, ratios, and institutional activity refreshed after every 10-K, 10-Q, 13F, and Form 4 filing.
Which hedge funds own GUTS?
Institutional investors are required to disclose their holdings quarterly via SEC Form 13F. 13F Pro aggregates these filings to show which hedge funds, mutual funds, and asset managers are buying or selling GUTS. Combined with insider transaction data from Form 4 filings and AI-powered analysis from 10 specialized research agents, 13F Pro provides a comprehensive view of FRACTYL HEALTH, INC.'s investment landscape.